Better out than in, they say? At least that seems to be the general consensus amongst the who’s who of the wellness community—where colonics seem to be all the rage. If you’re not familiar with the ...

January 27, 2012 (San Francisco, California) — Adjuvant therapy with capecitabine plus oxaliplatin (XELOX) significantly improves overall survival, compared with ...

Using a pooled data set of 3,302 patients with stage II and III colon cancer from seven randomized trials comparing FU + leucovorin or FU + levamisole to surgery alone, we performed an analysis based ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

The usefulness of adjuvant chemotherapy after surgery for stage II colon cancer is unclear; many patients are treated to benefit a few. Are there biomarkers that might indicate which patients are at ...